Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Aquagenic syringeal acrokeratoderma is a rare condition affecting the palms of the hands. It is characterized by the appearance or worsening of a palmar eruption, following brief exposure to water. The palmar eruption is made up of small, white or shining pimples that can conjoin into plaques. The feet are unaffected. Symptoms include a burning pain and a tightening sensation in the palms, as well as too much sweating. There are two variants. Most commonly, it is a temporary and recurrent condition that appears after submersion in water, known as the bhand in the bucket sign,b that gets better within minutes to hours of drying. A less common variant is characterized by persistent lesions that are worsened after water submersion. The cause of aquagenic syringeal acrokeratoderma is unknown, but likely relates to sweating. Several studies have found that it is present in about 40% to 84% of cystic fibrosis patients and also in carriers, which suggest that it may be caused by mutations in the CFTR gene. It is more often found in young women. Besides cystic fibrosis, it is also seen in wasting (marasmus) and nephrotic syndrome and also with the use of aspirin and other drugs such as rofecoxib and celecoxib. In most cases it does not need any treatment and resolves spontaneously. When necessary, it can be treated with topical aluminum chloride or salicylic acid ointment or with tap water iontophoresis.
Biomarker and diagnostic research for aquagenic palmoplantar keratoderma has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for aquagenic palmoplantar keratoderma.
18 publications have been identified in PubMed for aquagenic palmoplantar keratoderma. Research spans Case Report / Case Series (44%), Other (33%), and Review / Meta-Analysis (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 8 | 44% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 9:39 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
6 |
33% |
Research summaries | 3 | 17% |
Testing and diagnosis research | 1 | 6% |
Bimbi C (2026). [PMID: 42246360](https://pubmed.ncbi.nlm.nih.gov/42246360/). *Dermatol Online J*. [Case Report / Case Series]
Alexopoulos A (2026). [PMID: 41773128](https://pubmed.ncbi.nlm.nih.gov/41773128/). *Cureus*. [Diagnostic / Biomarker]
Piątkiewicz M (2026). [PMID: 41884385](https://pubmed.ncbi.nlm.nih.gov/41884385/). *Clin Cosmet Investig Dermatol*. [Review / Meta-Analysis]
Shan J (2026). [PMID: 41869430](https://pubmed.ncbi.nlm.nih.gov/41869430/). *Clin Cosmet Investig Dermatol*. [Case Report / Case Series]
Mansour M (2026). [PMID: 41716924](https://pubmed.ncbi.nlm.nih.gov/41716924/). *Oxf Med Case Reports*. [Case Report / Case Series]
Trager A (2026). [PMID: 40944350](https://pubmed.ncbi.nlm.nih.gov/40944350/). *Int J Dermatol*. [Other]
Bacchiega NS (2025). [PMID: 41311140](https://pubmed.ncbi.nlm.nih.gov/41311140/). *Ugeskr Laeger*. [Other]
Manoh J (2025). [PMID: 39853622](https://pubmed.ncbi.nlm.nih.gov/39853622/). *Indian J Pediatr*. [Other]
Aparício Martins I (2025). [PMID: 39932840](https://pubmed.ncbi.nlm.nih.gov/39932840/). *Acta Med Port*. [Case Report / Case Series]
Alsoweilem MK (2025). [PMID: 40018333](https://pubmed.ncbi.nlm.nih.gov/40018333/). *J Family Community Med*. [Case Report / Case Series]